Table 6.
Detailed microbiology of infections
| Patient number | Causative organism | Antibiotics used (length of course) |
|---|---|---|
| 1 | Coagulase-negative Staphylococcus and Enterococcus spp | Meropenem and vancomycin (4 weeks), then metronidazole (4 weeks) |
| 2 | Staphylococcus aureus | Rifampicin, metronidazole and clindamycin (2 weeks) |
| 3 | S aureus | Rifampicin and flucloxacillin (2 weeks), then doxycycline (6 weeks) |
| 4 | S aureus | Rifampicin and flucloxacillin (7 weeks) |
| 5 | Skin flora only | Vancomycin and rifampicin (2 weeks), then flucloxacillin and fusidic acid (2 weeks) |
| 6 | Coliform | Rifampicin and clindamycin (9 weeks) |
| 7 | Proteus spp | Flucloxacillin (3 weeks), then piperacillin/tazobactam (1 week), then vancomycin and rifampicin (2 weeks) |
| 8 | Coagulase-negative Staphylococcus | Flucloxacillin (10 weeks) |
| 9 | S aureus | Rifampicin and flucloxacillin (4 weeks) |
| 10 | MRSA | Vancomycin, rifampicin, gentamicin, mupirocin and chlorhexidine (2 weeks), then doxycycline and rifampicin (4 weeks) |
| 11 | Coliform | Meropenem (2 weeks), then ertapenem (5 weeks) |
| 12 | Enterococcus spp | Flucloxacillin, amoxicillin (10 weeks) and gentamicin (first 2 weeks only) |
| 13 | Coliform and Klebsiella pneumoniae | Rifampicin and flucloxacillin (6 weeks) |
| 14 | S aureus and Group A Streptococcus | Co-amoxiclav (2 weeks) |
| 15 | MRSA and Enterococcus spp | Flucloxacillin and gentamicin (2 weeks), then clindamycin (2 weeks), mupirocin and chlorhexidine (thoughout) |
| 16 | S aureus and Enterococcus spp | Rifampicin, metronidazole and clindamycin (2 weeks) |